reports
Pooya Hemami
- Pooya Hemami
Acerus Pharmaceuticals - Growing Canadian specialty pharma business
Acerus commercialises selected specialty pharmaceutical products in Canada and relies on partners for the US and other markets. Natesto sales growth in North America, along with other new products to be launched over the next 24 months, could potentially enable Acerus to deliver positive ongoing cash flows and EBITDA by the end of this period.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.